Public Citizen logo

Removing State Class Actions To Federal Courts:
Are Federal Courts Really Superior?

Rhetoric regarding the superior nature of the federal courts has been flowing fast and furious in the discussion surrounding the federalization of state-based class actions proposed under S. 353 and H.R. 1875. While there are abuses in state court class actions, the premise that these abuses will disappear upon removal to the federal courts is flawed. Too often, proposed class action settlements in both state and federal courts are reviewed perfunctorily with little regard for consumers' interests. These abuses generally manifest themselves in two ways: the undervaluation of plaintiffs' claims and the overvaluation of plaintiffs' attorneys fees. Such arrangements often occur through collusion between the attorneys for the defendants and plaintiffs. However, nothing in S. 353 or H.R. 1875 addresses either of these issues. Allowing the removal of the majority of state-based class actions is definitely not the solution, as class action abuse occurs in the federal courts as well.

Consider the following results in the preliminary Federal Judicial Center study looking at class actions in two federal district courts:

As John C. Coffee, Jr. stated in his Columbia Law Review article, Class Wars: The Dilemma of the Mass Tort Class Action, these statistics demonstrate a pattern in the federal courts of "judicial passivity" regarding class action settlements.

This "judicial passivity" can have a devastating impact on injured plaintiffs in federal class actions. Consider the following federal cases where the courts have approved class actions settlements that do little or nothing to help injured plaintiffs:

The same case contains another problematic ruling by a federal judge. Some plaintiffs allege claims against their surgeons on the ground that the surgeons should have warned of FDA refusal to approve the AcroMed bone screw implanted in their bodies. Plaintiffs also claim that surgeons and hospitals took stock from AcroMed and put those financial interests ahead of their patients in a clear conflict of interest. However, the settlement bars claims against the surgeons who implanted the screws and hospitals where the surgeries took place, despite the fact that those surgeons and hospitals were not parties to the settlement and the class received nothing in exchange for dropping their claims against those surgeons and hospitals. The settlement release goes so far as to bar claims against doctors who told their patients that the device was FDA approved when they knew it was not. AcroMed defends the release of the surgeons and hospitals on the ground that it needs to maintain good relations with its customers to insure future profitability.

Moreover, many state court judges carefully scrutinize proposed settlements and refuse to accept collusive settlements. Consider the following state cases where the courts refused to rubber-stamp class actions settlements and forced the parties to do a better job of protecting consumers:

It is clear that there are abusive class action settlements in both state and federal court. To assume that removing the vast majority of state class actions to federal court will solve this problem is erroneous. Nothing in either of these bills takes this into account and they are not the way to solve anti-consumer abuses in the class action system.


Back to Class Action Fact Sheets

Back to Main Class Action Page

Back to Civil Justice Page

Back to Congress Watch Home Page